EPA and DHA Market, By Source (Fish Oil, Algal Oil, Krill Oil, and Others), By Form (Liquid, Capsules and Soft gels, Powder, and Others), By Application (Dietary Supplements, Food and Beverages, Pharmaceuticals, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Published In : Dec 2024

Code : CMI5200

Pages :153

Formats :

Excel and PDF

Industry : Food and Beverages

EPA and DHA Market Size and Trends

Global EPA and DHA market is estimated to be valued at USD 1.93 Bn in 2024 and is expected to reach USD 3.05 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2024 to 2031.

EPA and DHA Market Key Factors

To learn more about this report, Request sample copy

Rising health-consciousness among consumers and growing awareness about the health benefits of EPA and DHA in preventing various diseases such as cardiovascular diseases, cancer, diabetes, and others can boost demand for EPA and DHA ingredients. Moreover, the increasing usage of EPA and DHA in infant formulas, pharmaceuticals and clinical nutrition drives the market growth of EPA and DHA globally.

EPA and DHA Market Concentration By Players

To learn more about this report, Request sample copy

Top Strategies Followed by Global EPA and DHA Market Players

Established players in this market have primarily focused on research and development to drive innovation. Leading companies like BASF, DSM, and Croda continually invest extensively in R&D activities to introduce high-performance and value-added products. These conduct extensive clinical trials and research to expand the application areas of EPA and DHA.
Mid-size players in the market have adopted cost-effective strategies to cater to price-sensitive consumers. These focus on optimizing production processes and utilizing economical resources to develop affordable EPA and DHA ingredients and supplements.
Small-scale companies operating in this market have specialized in specific industry segments or regional markets. These introduce innovative products meeting the custom needs of niche consumer groups. Some cater to vegan consumers by sourcing algal-derived DHA and EPA. Others have localized their production and marketing to better serve regional health trends.

Emerging Startups in the Global EPA and DHA Market

Innovative Technologies- Startups are applying technologies like bioengineering and AI to develop advanced solutions. OmegaVia employs precision fermentation to produce customized algal oils clinically-proven to raise DHA and EPA levels. These innovations could reshape the market by enabling personalized supplementation based on lifestyle and genetics.

Sustainable Solutions- Other startups focus on sustainability. Kaleido Biosciences produces DHA and EPA through the fermentation of non-GMO corn, avoiding stress on fish stocks. Good Ocean invests in kelp aquaculture as an eco-friendly DHA source. These startups help address concerns around sourcing and expand the market potential of plant- and algae-based omega-3s.

Market Contribution- Startups like Terravia are meeting specific market demands by producing algal DHA and EPA for food applications such as baked goods and plant-based meats. By offering unique fortification options, these companies are creating new segments and applications that complement the offerings of traditional, large-scale producers.